We analysed RNAseq data available for these endometrial cancer samples and showed that CTCF gene expression was not significantly decreased in CTCF-altered cancers despite the presence of inactivating mutations (Supplementary Figure S3A). The gene discussed is CTCF; the disease is endometrial cancer.